Sen. Bernie Sanders (I-VT) (AP Photo/Mariam Zuhaib)
February 6, 2024 02:22 PM EST
Pharma
FDA+

Will an up­com­ing Sen­ate hear­ing help low­er drug prices? It de­pends who you ask

Nicole DeFeudis

Editor

Days be­fore three phar­ma CEOs are set to tes­ti­fy be­fore the Sen­ate on high pre­scrip­tion drug prices, mem­bers of the Com­mit­tee on Health, Ed­u­ca­tion, La­bor …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times